Definium Therapeutics (DFTX) Balance Sheet: Assets & Liabilities

Definium Therapeutics (DFTX) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Definium Therapeutics reported total assets of $440.10M and total liabilities of $107.77M. Shareholders' equity was $332.33M, up 37.6% from $241.45M a year earlier. Total debt stood at $40.58M against $411.59M in cash and short-term investments, a net cash position of $371.01M. That puts debt-to-equity at 0.12, compared with 0.09 a year earlier.

Definium Therapeutics Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Definium Therapeutics, Inc. (DFTX) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Mar 2020	Aug 2018	Aug 2017
Current Assets
Cash and Cash Equivalents	257.84	273.74	99.70	142.14	133.54	80.09	0.02	0.15	0.00
Short-Term Investments	153.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.69
Cash & Short-Term Investments	411.59	273.74	99.70	142.14	133.54	80.09	0.02	0.15	1.69
Accounts Receivable	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.01	0.01
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	7.73	7.88	4.17	3.91	3.68	1.43	2.91	0.04	0.07
Total Current Assets	419.32	281.62	103.87	146.06	137.22	81.52	2.94	0.20	1.77
Non-Current Assets
Property, Plant & Equipment (Net)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.06	0.07
Long-Term Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.14	0.07
Goodwill	19.92	19.92	19.92	19.92	19.92	0.00	0.00	0.00	0.00
Intangible Assets	0.00	0.00	0.53	3.69	6.87	0.00	0.00	0.00	0.00
Other Non-Current Assets	0.86	0.61	0.22	0.33	0.00	0.00	0.00	3.13	2.12
Total Non-Current Assets	20.78	20.53	20.67	23.94	26.79	0.00	0.00	3.33	2.26
Total Assets	440.10	302.15	124.54	169.99	164.00	81.52	2.94	3.53	4.03
Current Liabilities
Accounts Payable	5.35	2.01	4.14	2.11	4.18	2.02	0.00	0.00	0.00
Short-Term Debt	0.00	0.00	0.00	0.07	0.00	0.00	0.00	0.00	0.02
Accrued Liabilities	10.98	6.42	4.27	1.11	6.23	0.99	-	-	-
Other Current Liabilities	40.91	24.01	16.48	9.90	6.23	0.99	0.20	0.01	0.06
Total Current Liabilities	66.70	38.85	32.25	17.89	10.41	3.01	0.20	0.01	0.08
Non-Current Liabilities
Long-Term Debt	40.58	21.85	14.13	0.00	0.00	0.00	0.00	0.00	0.00
Other Non-Current Liabilities	0.50	0.00	0.03	1.18	1.93	2.64	0.00	0.00	0.00
Total Non-Current Liabilities	41.08	21.85	14.16	1.18	1.93	2.64	0.00	0.00	0.00
Total Liabilities	107.77	60.70	46.41	19.08	12.34	5.65	0.20	0.01	0.08
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.00	0.00	5.56	5.32	5.16
Retained Earnings	-582.67	-398.88	-290.20	-194.47	-137.67	-44.64	-3.65	-2.59	-1.81
Accumulated Other Comprehensive Income	1.09	0.82	0.34	0.63	1.05	0.28	0.03	0.02	-0.04
Additional Paid-in Capital	913.91	639.51	367.99	344.76	288.29	120.22	0.80	0.77	0.65
Shares Outstanding	98.78	75.10	41.10	37.98	28.10	-	-	-	-
Total Stockholders' Equity	332.33	241.45	78.13	150.92	151.66	75.87	2.74	3.52	3.95
Total Liabilities & Equity	440.10	302.15	124.54	169.99	164.00	81.52	2.94	3.53	4.03

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Definium Therapeutics Balance Sheet

How much debt does Definium Therapeutics have?

Definium Therapeutics had total debt of $40.58M as of Dec 31, 2025, against $411.59M in cash and short-term investments. Its debt-to-equity ratio was 0.12. Total debt was $21.85M a year earlier.

What are Definium Therapeutics's total assets?

Definium Therapeutics reported total assets of $440.10M as of Dec 31, 2025, up 45.7% from $302.15M a year earlier. Total liabilities were $107.77M.

What is Definium Therapeutics's shareholders' equity?

Definium Therapeutics's shareholders' equity was $332.33M as of Dec 31, 2025, or about $3.36 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition